Posts

Posted on

Liver ablation articles

  1. Li, HS, Zhang, XF, Fu, J, Yuan, B. Efficacy of microwave ablation vs laparoscopic hepatectomy for primary small liver cancer: A comparative study. World J Gastrointest Surg. 2025;17 (3):101786. doi: 10.4240/wjgs.v17.i3.101786. PubMed PMID:40162382 PubMed Central PMC11948124.
  2. Fu, X, Gu, L, Xu, J, Li, J. The effect of ultrasound-guided microwave ablation on liver function and short-term efficacy in patients with postoperative recurrence of liver cancer. Curr Probl Surg. 2025;65 :101734. doi: 10.1016/j.cpsurg.2025.101734. PubMed PMID:40128005 .
  3. Gao, W, Zhang, Q, Ma, L, He, N, Zhang, Y, Yuan, C et al.. The Safety Evaluation of TAE for Ruptured Hepatocellular Carcinoma and Ablation-Related Hemorrhage, and the Clinical Significance of Postoperative Liver Function Changes. Transplant Proc. 2025; :. doi: 10.1016/j.transproceed.2025.02.043. PubMed PMID:40107933 .
  4. Odisio, BC, Albuquerque, J, Lin, YM, Anderson, BM, O'Connor, CS, Rigaud, B et al.. Software-based versus visual assessment of the minimal ablative margin in patients with liver tumours undergoing percutaneous thermal ablation (COVER-ALL): a randomised phase 2 trial. Lancet Gastroenterol Hepatol. 2025; :. doi: 10.1016/S2468-1253(25)00024-X. PubMed PMID:40090348 .
  5. Burgmans, MC. Software-based quantitative assessment of ablation margins: a new standard for liver tumour ablation. Lancet Gastroenterol Hepatol. 2025; :. doi: 10.1016/S2468-1253(25)00061-5. PubMed PMID:40090345 .
  6. Abdlaty, R, Abbass, MA, Awadallah, AM. Toward near real-time precise supervision of radiofrequency ablation for liver fibrosis using hyperspectral imaging. Spectrochim Acta A Mol Biomol Spectrosc. 2025;336 :125994. doi: 10.1016/j.saa.2025.125994. PubMed PMID:40086137 .
  7. Qi, XG, Li, JM, Dou, JP, Liu, FY, Wang, Z, Zhang, ZH et al.. Decision-Making for Ablation of Colorectal Liver Oligometastases Patients: A 10-Year Retrospective Study of Survival Outcomes Based on Right-Versus Left-Sided Primary Tumor Location. Cancer Control. 2025;32 :10732748251324627. doi: 10.1177/10732748251324627. PubMed PMID:40085923 PubMed Central PMC11909683.
  8. Rajeev, R, Hussain, HK. Thermal Ablation versus Surgical Resection for Management of Small Colorectal Liver Metastases: Insights from the COLLISION Trial. Radiol Imaging Cancer. 2025;7 (2):e259008. doi: 10.1148/rycan.259008. PubMed PMID:40084950 .
  9. Tawfeeq, HR, Lackey, AI, Zhou, Y, Diolintzi, A, Zacharisen, SM, Lau, YH et al.. Tissue-Specific Ablation of Liver Fatty Acid-Binding Protein Induces a Metabolically Healthy Obese Phenotype in Female Mice. Nutrients. 2025;17 (5):. doi: 10.3390/nu17050753. PubMed PMID:40077623 PubMed Central PMC11901660.
  10. Kong, Y, Huang, X, Cao, X, Tang, F, Zhou, X. Early Recurrence of Colorectal Liver Metastasis (Number ≤ 5 and Largest Diameter ≤ 3 cm) after Resection or Thermal Ablation: a Multi-center Study of Patterns, Safety, Survival and Risk Factors. J Gastrointest Cancer. 2025;56 (1):77. doi: 10.1007/s12029-025-01200-4. PubMed PMID:40072796 .
  11. Kuang, M, Wang, W, Lin, MX, Xie, WX, Xiao, H, Zeng, Y et al.. [Progress in ablation therapy for liver cancer and multidisciplinary application]. Zhonghua Wai Ke Za Zhi. 2025;63 (4):271-275. doi: 10.3760/cma.j.cn112139-20241107-00497. PubMed PMID:40058776 .
  12. Nishi, Y, Sakamoto, K, Uraoka, M, Nagaoka, T, Honjo, M, Tamura, K et al.. Liver resection in patients with a history of local ablation for hepatocellular carcinoma has the risk of poor survival and serosal invasion. Ann Gastroenterol Surg. 2025;9 (2):347-358. doi: 10.1002/ags3.12872. PubMed PMID:40046521 PubMed Central PMC11877331.
  13. Yin, J, Zhao, Y, Yin, J, Yang, S. Efficacy of transarterial chemoembolization combined with radiofrequency ablation in the treatment of liver metastases from colorectal cancer. Clin Transl Oncol. 2025; :. doi: 10.1007/s12094-025-03879-0. PubMed PMID:40042572 .
  14. Chiang, J, Sparks, H, Hao, F, Lee, EW, Sung, K. Numerical modeling and validation of combination embolization-ablation therapy in the liver using dynamic contrast-enhanced (DCE)-MRI. Annu Int Conf IEEE Eng Med Biol Soc. 2024;2024 :1-5. doi: 10.1109/EMBC53108.2024.10781570. PubMed PMID:40039695 .
  15. Liew, SQR, Rex, N, Hsieh, C, Kim, H, Collins, SA, Baird, GL et al.. An automated software algorithm for optimizing microwave ablation parameters for treatment of liver tumors. Int J Hyperthermia. 2025;42 (1):2473391. doi: 10.1080/02656736.2025.2473391. PubMed PMID:40037702 .
  16. Yang, M, Li, G, Chen, K, Wu, Y, Sun, T, Wang, W et al.. Liver resection versus radiofrequency ablation for solitary small hepatocellular carcinoma measuring≤3cm: a systematic review and meta-analysis. Int J Surg. 2025; :. doi: 10.1097/JS9.0000000000002302. PubMed PMID:39998503 .
  17. Wang, Y, Chen, Z, Wei, B, Zhang, R, Zhang, X, Xu, W et al.. Metabolic dysfunction associated steatotic liver disease is associated with atrial fibrillation recurrence following cryoballoon ablation. Sci Rep. 2025;15 (1):6287. doi: 10.1038/s41598-025-90667-z. PubMed PMID:39984596 PubMed Central PMC11845672.
  18. Georgiades, M, March, C, Barajas Ordonez, F, Omari, J, Powerski, M, Grosser, OS et al.. Hepatic Hilar Nerve Block for Adjunctive Analgesia in Thermal Ablation of Liver Tumors: A Prospective Randomized Controlled Trial. Rofo. 2025; :. doi: 10.1055/a-2528-7037. PubMed PMID:39978353 .
  19. Gu, D, Liu, D, Yao, H, Rui, D, Yang, Y, Zhou, Y et al.. Algorithm-controlled RF power output for enhanced margin precision in liver cancer radiofrequency ablation. Biomed Mater Eng. 2025;36 (2):133-147. doi: 10.1177/09592989241304992. PubMed PMID:39973235 .
  20. Huang, J, Xie, H, Li, J, Huang, X, Cai, Y, Yang, R et al.. Histone lactylation drives liver cancer metastasis by facilitating NSF1-mediated ferroptosis resistance after microwave ablation. Redox Biol. 2025;81 :103553. doi: 10.1016/j.redox.2025.103553. PubMed PMID:39970777 PubMed Central PMC11876915.
Search PubMed
Posted on

Renal ablation articles

  1. Torres, TP, Liakopoulos, I, Balomenos, V, Grigoriadis, S, Papakonstantinou, O, Kelekis, N et al.. Adjunctive techniques for renal cell carcinoma ablation: an update. Front Radiol. 2025;5 :1559411. doi: 10.3389/fradi.2025.1559411. PubMed PMID:40165795 PubMed Central PMC11955682.
  2. Askarpour, M, Aminsharifi, A. Minimally Invasive Salvage Approaches for Management of Recurrence After Primary Renal Mass Ablation. Cancers (Basel). 2025;17 (6):. doi: 10.3390/cancers17060974. PubMed PMID:40149308 PubMed Central PMC11940802.
  3. Chan, VW, Ng, HH, Abdulrauf, K, Zaman, H, Ahmed, A, Zhong, J et al.. Percutaneous Image-Guided Ablation of Renal Cancer: Traditional and Emerging Indications, Energy Sources, Techniques, and Future Developments. Medicina (Kaunas). 2025;61 (3):. doi: 10.3390/medicina61030438. PubMed PMID:40142250 PubMed Central PMC11943572.
  4. Baer, BR, Matheny, MV, Mercedes, RH, Raman, JD. Comparative Analysis of Long-Term Renal Outcomes in Upper Tract Urothelial Carcinoma: Local Ablation Versus Radical Nephroureterectomy. Curr Oncol. 2025;32 (3):. doi: 10.3390/curroncol32030125. PubMed PMID:40136329 PubMed Central PMC11940996.
  5. Travesso, DJ, de Melo, RAB, Almeida, MFA, Motta-Leal-Filho, JM, Moura, EBS, Machado, F et al.. T1b Renal Masses Radiofrequency Ablation: Feasibility, Safety, and Efficacy in Midterm Follow-Up. Int J Urol. 2025; :. doi: 10.1111/iju.70042. PubMed PMID:40062605 .
  6. Cassim, R, Bansal, R, Millan, B, Mironov, O, Ahir, P, Tajzler, C et al.. A Randomized Trial of Stereotactic Body Radiation Therapy vs Radiofrequency Ablation for the Treatment of Small Renal Masses: A Feasibility Study (RADSTER). Urology. 2025; :. doi: 10.1016/j.urology.2025.02.053. PubMed PMID:40058468 .
  7. Schaarschmidt, BM, Zensen, S, Kesch, C, Dertnig, T, Opitz, M, Drews, M et al.. Current use of percutaneous ablation in renal tumors: an analysis of the registry of the German Society for Interventional Radiology and Minimally Invasive Therapy. Eur Radiol. 2025;35 (3):1723-1731. doi: 10.1007/s00330-024-11343-w. PubMed PMID:40016555 PubMed Central PMC11868359.
  8. Carbonara, U, Ditonno, F, Beksac, AT, Derweesh, I, Cerrato, C, Celia, A et al.. Percutaneous Cryotherapy and Radiofrequency Ablation of Renal Masses: Multicenter Comparative Analysis with Minimum 3-Year Follow-up. Int Braz J Urol. 2025;51 (2):. doi: 10.1590/S1677-5538.IBJU.2024.0565. PubMed PMID:39913094 PubMed Central PMC11884627.
  9. Wells, SA, Shapiro, D, Borza, T, Allen, G, Hinshaw, JL, Ziemlewicz, TJ et al.. Percutaneous microwave ablation of cT1b renal cell carcinoma: safety and oncologic efficacy in a large, single-center elderly and comorbid cohort. Abdom Radiol (NY). 2025; :. doi: 10.1007/s00261-024-04794-8. PubMed PMID:39912925 .
  10. Li, G, Chen, Y, Zhang, X. Percutaneous laser ablation vs. radical nephroureterectomy: a comparative study on renal pelvic tumors. Int Urol Nephrol. 2025; :. doi: 10.1007/s11255-025-04395-4. PubMed PMID:39904823 .
  11. Elhakim, TS, Lodhi, T, Fidelis, W, Brea, A, Mort, A, Mohagheghtabar, M et al.. Management of renal cell carcinoma with ablation in comparison to nephrectomy: A 5-year analysis of inpatient procedural data to evaluate utilization disparities in the United States. Clin Imaging. 2025;119 :110412. doi: 10.1016/j.clinimag.2025.110412. PubMed PMID:39862649 .
  12. Ochsner, A, Malshy, K, Golijanin, B, Mega, A, Collins, S, Maxwell, A et al.. Adrenal Metastasis Ablation in Oligometastatic Renal Cell Carcinoma: A Case Series. Clin Genitourin Cancer. 2025;23 (2):102295. doi: 10.1016/j.clgc.2024.102295. PubMed PMID:39854956 .
  13. Justo-Jaume, C, Stempel, M, Qiu, J, Gonzalez Miranda, L, Yan, G, Lyons, G et al.. Efficacy and safety of microwave ablation in solitary kidney patients with T1a small renal masses. Abdom Radiol (NY). 2025; :. doi: 10.1007/s00261-024-04779-7. PubMed PMID:39775024 .
  14. Tyagi, SC. Epigenetics of Homocystinuria, Hydrogen Sulfide, and Circadian Clock Ablation in Cardiovascular-Renal Disease. Curr Issues Mol Biol. 2024;46 (12):13783-13797. doi: 10.3390/cimb46120824. PubMed PMID:39727952 PubMed Central PMC11726923.
  15. Hasegawa, T, Vroomen, LGPH, Sivaraman, A, Fujimori, M, John, NT, Coleman, J et al.. Effect of Transforming Growth Factor-β Inhibition on Ureteral and Renal Scarring in a Rat Model of Upper Urinary Tract Ablation with Irreversible Electroporation. Bioelectricity. 2024;6 (4):272-279. doi: 10.1089/bioe.2024.0022. PubMed PMID:39712219 PubMed Central PMC11656016.
  16. Ravizzini, PI, Lino, HA, Ravizzini, G, Toledo, LGM. Percutaneous radiofrequency ablation of an actively bleeding renal angiomyolipoma. Einstein (Sao Paulo). 2024;22 :eRC1008. doi: 10.31744/einstein_journal/2024RC1008. PubMed PMID:39699407 PubMed Central PMC11634353.
  17. Zhou, V, Zhou, W, Herwald, SE, Arellano, RS. CT-guided microwave ablation of renal cell carcinoma in a horseshoe kidney. Radiol Case Rep. 2025;20 (2):1030-1033. doi: 10.1016/j.radcr.2024.10.142. PubMed PMID:39654582 PubMed Central PMC11626640.
  18. Yang, B, Zheng, Y, Zheng, M, Wang, D, Ren, S, Tian, J et al.. Partial nephrectomy versus radiofrequency ablation in patients with cT1a renal cell carcinoma: A surveillance, epidemiology, end results (SEER) analysis. Medicine (Baltimore). 2024;103 (48):e40721. doi: 10.1097/MD.0000000000040721. PubMed PMID:39612442 PubMed Central PMC11608729.
  19. Lucignani, G, Rizzo, M, Ierardi, AM, Piasentin, A, De Lorenzis, E, Trombetta, C et al.. A Trifecta-Based Evaluation of Patients Treated with Percutaneous Thermal Ablation of Small Renal Masses. J Endourol. 2025;39 (S2):S38-S45. doi: 10.1089/end.2024.0091.fts24. PubMed PMID:39612165 .
  20. Becher, E. Editorial Comment on A Trifecta-Based Evaluation of Patients Treated with Percutaneous Thermal Ablation of Small Renal Masses by G. Lucignani, et. al. J Endourol. 2025;39 (S2):S46. doi: 10.1089/end.2024.0767. PubMed PMID:39588916 .
Search PubMed